BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28/07/2021

FDA Announces Draft Guidance for Olodaterol Hydrochloride; Tiotropium Bromide Inhalation Spray

The FDA has released a draft guidance document outlining product-specific recommendations for demonstrating bioequivalence to support abbreviated new drug applications for olodaterol hydrochloride; tiotropium bromide inhalation spray.

Source: Federal Register — Food and Drug AdministrationOpen original release →